Learn how Dupixent helps diverse eczema patients and why inclusive clinical trials are vital for fair healthcare.

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Nektar’s shares have surged more than twofold after a Phase IIb study of its atopic dermatitis (AD) therapy rezpegaldesleukin ...

Discover life-changing eczema treatments and remedies that provide real relief. From prescription breakthroughs to natural solutions that actually work.

Cibinqo is an oral medication designed for patients aged 12 and above who suffer from moderate-to-severe eczema, and who have not responded well to topical treatments.

This NIHR Collection brings together major studies on the prevention and treatment of eczema, highlighting which interventions are effective and which do not appear to help. Other studies explore what ...

Rinvoq is an oral JAK inhibitor pill for use in ages 12 and up. Abrocitinib (Cibinqo) is another oral JAK inhibitor treatment. Prescription-strength moisturizers. These support the skin’s barrier.

Oral medications are drugs that someone takes by mouth that then undergo absorption into the bloodstream. The oral drugs for eczema are immunosuppressants, which are medications that prevent ...

Living with eczema affects more than just the skin – it influences everything from sleep patterns to clothing choices and social interactions. This inflammatory skin condition, which comes from ...

A new class of medications referred to as JAK inhibitors can help change patient’s lives by reducing inflammation and itch. Many patients experience quick relief and are thrilled they don’t ...

Sanofi and Regeneron's Dupixent, Leo Pharma's Anzupgo could help close treatment gap in chronic hand eczema: GlobalData By Andrea Park Dec 19, 2024 3:35pm eczema atopic dermatitis Leo Pharma Dupixent ...